Ushering In a New Era of Drug Prices, Part 1: The DTC Revolution

Unconventional pathways and creative policymaking have already upended the pharmaceutical sector this year, and more changes are expected that have the potential to reshape U.S. drug pricing permanently. Part one of this two-part series explores the history of most-favored-nation drug prices and direct-to-consumer drug sales.